From Prompt to Drug: Toward Pharmaceutical Superintelligence

Area of Science:

• Pharmacology
• Artificial Intelligence
• Laboratory Automation

Background:

• Generative artificial intelligence (AI) platforms are rapidly evolving.
• Automated laboratory systems offer precise and reproducible experimental execution.
• The integration of these technologies presents a novel opportunity in pharmaceutical research.

Purpose of the Study:

• To explore the convergence of generative AI and automated laboratory systems.
• To present a "prompt-to-drug" pipeline for autonomous drug discovery.
• To outline a vision for scalable, efficient, and unbiased drug development.

Main Methods:

• Review of recent advancements in AI technologies for drug discovery.
• Description of a "prompt-to-drug" pipeline integrating AI and automation.
• Highlighting key breakthroughs and case studies in AI-driven drug development.
• Discussion of the required technological infrastructure for closed-loop systems.

Main Results:

• AI can generate novel hypotheses and design optimized drug candidates.
• AI can orchestrate synthesis, validation, and clinical planning.
• The "prompt-to-drug" pipeline enables a fully autonomous, end-to-end drug development program.
• Key breakthroughs demonstrate the feasibility of AI-driven autonomous drug discovery.

Conclusions:

• The convergence of generative AI and automation marks a new era in drug discovery.
• This paradigm shift enables a scalable, efficient, and unbiased approach to developing therapeutics.
• The "prompt-to-drug" pipeline offers a vision for the future of pharmaceutical research and development.